NewAmsterdam Pharma Announces Closing of Upsized Secondary Offering of Ordinary Shares
NAARDEN, The Netherlands and MIAMI, June 09, 2023 -- NewAmsterdam Pharma Company N.V. , a clinical-stage biopharmaceutical company developing oral, non-statin medicines for patients at high risk of... | June 9, 2023